OQY-3258, also known as ESG401, is an anti-TROP2 ADC currently under evaluation in three clinical trials: A Phase 1a/1b clinical trial for patients with solid tumors (NCT04892342). A Phase 3 study in ...

Arm China plans to tap Chen Feng (陳鋒), a former executive at Fuzhou, Fujian Province-based chipmaker Rockchip Electronics Co ...

Legacy of Trust and Expertise Ushers in New Era of Precision Medical Device Development and Manufacturing Capabilities ...

Explore how AI is transforming the fight against counterfeit goods, improving European soft IP protection and reducing ...

Amy also shares the importance of getting to know the individuals behind the big Pharma logos, which helps patients ... about pushing the diabetes world to design these devices.

Sol de Janeiro is an American skincare and fragrance brand, founded in 2015 by Heela Yang, a former beauty industry marketing executive in the U.S., who moved to Brazil with her husband in 2008, and ...

HB-500 is a next-generation therapeutic vaccine being developed in collaboration with Gilead Sciences, Inc. (Gilead) as a potential component of ...

U.S. officials have approved a new type of pain drug designed to eliminate the risks of addiction and overdose associated with opioids.

A new $7.4 billion settlement with states has been reached with Purdue Pharma and its Sackler family owners. We'll unpack. Most of the money from a newly-reached settlement over the fallout of the ...

The yearslong bankruptcy case could be coming to a close. Purdue Pharma’s owners in the Sackler family have agreed to a new $6.5 billion settlement to lawsuits over their role in the U.S. opioid ...

Years of scouring the bush and breeding work at The University of Queensland have resulted in new varieties of a native Australian plant valuable to the global pharmaceutical industry ...

Operator Hello, and welcome to the fourth quarter and full year 2024 Teva Pharmaceutical Industries earnings conference call.